Status:

COMPLETED

Protocol for Postmenopausal Women at Increased Risk of Developing Breast Cancer

Lead Sponsor:

Carol Fabian, MD

Conditions:

Breast Cancer

Eligibility:

FEMALE

18+ years

Brief Summary

To examine nipple aspirate fluid for secretions that may be identified as a high risk indicator for development of breast cancer, and compare those to serum analysis.

Detailed Description

To examine nipple aspirate fluid analysis in lactating women for local concentration of estrogen, prolactin, glucocorticoids, insulin, parity, prior lactation and age. NAF secretors have been reported...

Eligibility Criteria

Inclusion

  • women with high a high risk of breast cancer
  • Older than 18

Exclusion

  • anticoagulants
  • marked breast tenderness
  • pregnant or within twelve months of breast feeding/childbirth

Key Trial Info

Start Date :

October 1 2005

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

June 1 2008

Estimated Enrollment :

229 Patients enrolled

Trial Details

Trial ID

NCT00291083

Start Date

October 1 2005

End Date

June 1 2008

Last Update

February 7 2012

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University of Kansas Medical Center

Kansas City, Kansas, United States, 66160